tiprankstipranks
Trending News
More News >
IBI Investment House Ltd. (IL:IBI)
:IBI
Israel Market
Advertisement

Ibi Inv House (IBI) AI Stock Analysis

Compare
1 Followers

Top Page

IL:IBI

Ibi Inv House

(IBI)

Rating:58Neutral
Price Target:
23,078.00
▲(3.35% Upside)
Ibi Inv House's strong financial performance, characterized by high profitability and efficient operations, is offset by significant revenue decline and negative cash flow growth. The stock's technical indicators suggest bearish momentum, and while the valuation is moderate, it does not sufficiently counterbalance the technical weaknesses.
Positive Factors
Profitability and Margins
High profitability and strong margins indicate efficient operations and a robust business model, supporting long-term financial stability.
Leverage and Equity
A moderate debt-to-equity ratio reflects prudent financial management, providing flexibility and reducing risk in volatile markets.
Operational Efficiency
Strong EBIT and EBITDA margins highlight operational efficiency, ensuring the company can sustain profitability even amid revenue challenges.
Negative Factors
Revenue Decline
A substantial revenue decline poses a risk to growth prospects, potentially impacting the company's ability to invest in future opportunities.
Negative Cash Flow Growth
Declining free cash flow growth can strain financial resources, limiting the company's ability to fund operations and strategic initiatives.
Earnings Decline
A decline in EPS growth indicates challenges in maintaining profitability, potentially affecting investor confidence and future capital raising.

Ibi Inv House (IBI) vs. iShares MSCI Israel ETF (EIS)

Ibi Inv House Business Overview & Revenue Model

Company DescriptionIbi Inv House (IBI) is a financial services company specializing in investment management and advisory services. Operating primarily in the investment sector, IBI offers a range of products including mutual funds, private equity, and asset management services tailored to individual and institutional investors. The firm leverages advanced analytics and market insights to help clients achieve their financial goals through strategic investment solutions.
How the Company Makes MoneyIbi Inv House generates revenue primarily through management fees charged on the assets under management (AUM) in its investment funds. Additionally, the company earns performance fees tied to the success of its private equity investments and other managed portfolios. Advisory fees from consulting services provided to clients and institutions also contribute to its revenue stream. Significant partnerships with financial institutions and technology firms enhance its market presence and enable access to a broader client base, further driving earnings.

Ibi Inv House Financial Statement Overview

Summary
Ibi Inv House exhibits strong financial health with excellent profitability and efficient cash flow management. Despite a recent decline in revenue, the company maintains robust margins and a solid balance sheet with low leverage. The slight decline in free cash flow growth warrants monitoring, but the overall financial position remains strong and stable.
Income Statement
85
Very Positive
Ibi Inv House shows strong profitability with a high gross profit margin of 98.45% and a solid net profit margin of 20.38% for TTM. The revenue growth rate from 2024 to TTM is negative at -19.86%, indicating a recent decline in sales. However, the EBIT and EBITDA margins remain robust at 37.03% and 46.99%, respectively, showcasing efficient operational management.
Balance Sheet
78
Positive
The company maintains a healthy balance sheet with a low debt-to-equity ratio of 0.29, indicating conservative leverage. The return on equity (ROE) is strong at 19.93% for TTM, reflecting effective use of equity to generate profits. The equity ratio is 44.97%, suggesting a balanced capital structure with a significant portion of assets financed by equity.
Cash Flow
82
Very Positive
Ibi Inv House demonstrates strong cash flow management with a high operating cash flow to net income ratio of 1.48 for TTM, indicating efficient cash generation relative to earnings. The free cash flow to net income ratio is also favorable at 1.27. However, the free cash flow growth rate is slightly negative at -0.83%, suggesting a slight decline in cash generation compared to the previous period.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue562.71M1.04B791.55M660.61M589.40M435.79M
Gross Profit540.20M696.21M511.24M417.09M397.75M279.51M
EBITDA373.09M368.28M281.08M212.29M231.00M150.50M
Net Income132.62M178.14M156.46M90.76M139.58M81.94M
Balance Sheet
Total Assets1.97B1.85B1.27B1.08B1.13B1.02B
Cash, Cash Equivalents and Short-Term Investments546.48M519.23M453.00M246.53M442.65M297.47M
Total Debt302.87M243.90M201.26M154.42M334.90M197.25M
Total Liabilities888.19M750.27M539.07M399.48M521.39M469.80M
Stockholders Equity870.12M899.76M686.62M640.44M575.47M522.10M
Cash Flow
Free Cash Flow150.06M218.35M207.56M33.63M190.60M67.73M
Operating Cash Flow192.47M249.28M269.65M49.51M197.55M78.27M
Investing Cash Flow-58.13M-97.88M-269.38M-32.48M36.90M-83.19M
Financing Cash Flow-49.75M-141.00K-37.48M-80.76M-196.36M25.17M

Ibi Inv House Technical Analysis

Technical Analysis Sentiment
Negative
Last Price22330.00
Price Trends
50DMA
24712.55
Negative
100DMA
24099.99
Negative
200DMA
21117.40
Positive
Market Momentum
MACD
-648.57
Negative
RSI
39.93
Neutral
STOCH
52.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:IBI, the sentiment is Negative. The current price of 22330 is below the 20-day moving average (MA) of 22974.10, below the 50-day MA of 24712.55, and above the 200-day MA of 21117.40, indicating a neutral trend. The MACD of -648.57 indicates Negative momentum. The RSI at 39.93 is Neutral, neither overbought nor oversold. The STOCH value of 52.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:IBI.

Ibi Inv House Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.02B11.589.93%3.76%9.73%1.31%
58
Neutral
3.05B22.50
4.67%38.04%-28.49%
1.92B12.38
8.72%
4.78B17.33
3.53%
65
Neutral
3.37B10.52
6.62%24.23%48.82%
1.78B9.94
3.64%
76
Outperform
1.18B11.64
5.98%679.53%23.96%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:IBI
Ibi Inv House
22,330.00
10,201.97
84.12%
IL:FBRT
Fms
20,830.00
10,093.65
94.01%
IL:LAPD
Lapidoth Cap.
7,982.00
2,759.05
52.83%
IL:IDIN
Idi Insur
22,840.00
11,774.47
106.41%
IL:JBNK
Jerusalem
2,523.00
1,335.75
112.51%
IL:ATRY
Atreyu Cap
8,012.00
2,767.67
52.77%

Ibi Inv House Corporate Events

Ibi Inv House Ltd. Announces 2024 Annual Report Release Date and Investor Call
Feb 10, 2025

Ibi Inv House Ltd. has announced the publication date for its 2024 annual report, which will be released on March 24, 2025. The company will also hold an investor call on March 25, 2025, to review the annual report and provide a summary of the year 2024. This announcement signifies the company’s commitment to transparency and timely communication with its stakeholders. By providing clear timelines for the report and investor call, Ibi Inv House Ltd. is ensuring that investors and analysts are well-informed, which can positively impact its market perception.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 03, 2025